<DOC>
	<DOCNO>NCT00002654</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know radiation therapy plus chemotherapy effective radiation therapy alone treat patient advanced head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus cisplatin radiation therapy alone treat patient advanced head neck cancer .</brief_summary>
	<brief_title>Radiation Therapy With Without Cisplatin Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess time treatment failure ( local regional ) patient moderately advance advanced squamous cell carcinoma head neck ( distant metastasis ) treat hyperfractionated radiotherapy vs. without 2 course simultaneously administer cisplatin . II . Assess time distant metastatic relapse , overall survival , toxicity patient receive treatment . III . Evaluate whether potential tumor-doubling time indicator risk treatment failure patient receive treatment . OUTLINE : Randomized study . Arm I : Radiotherapy plus Single-Agent Chemotherapy follow , indicate , Surgery . Hyperfractionated external-beam tumor irradiation use photon energy 4-6 MV electron 6-12 MV ( interstitial brachytherapy boost lesion oral cavity allow ) ; plus Cisplatin , CDDP , NSC-119875 ; follow , patient persistent disease ( discretion surgeon ) , resection primary tumor involve node . Arm II : Hyperfractionated radiotherapy follow Surgery . Tumor irradiation Arm I ; follow resection Arm I . PROJECTED ACCRUAL : At least 400 patient accrue 5 year . Interim analysis allow early stopping carry entry 50 100 patient .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically document squamous cell cancer head neck follow site : Hypopharynx Larynx Oral cavity Oropharynx Stage III/IV disease No distant metastasis follow : Chest xray ( patient ) Liver ultrasound CT bone scintigraphy ( hypopharyngeal cancer , involve low neck node , clinically indicate ) Multiple sit disease eligible provide radiotherapy treatment volume remain acceptable PATIENT CHARACTERISTICS : Age : 20 75 Performance status : WHO 02 Hematopoietic : WBC great 3,000 Platelets great 100,000 Hepatic : Not specify Renal : Creatinine clearance least 60 ml/min No renal disease impairment renal function Cardiovascular : No coronary heart disease No cardiac failure No history pulmonary embolism within 2 year Other : No clinical hearing impairment No peripheral neuropathy concomitant handicap No severe diabetes mellitus serious vasculopathy neuropathy No second cancer except : Nonmelanomatous skin lip cancer In situ carcinoma cervix Blood/body fluid analyse determine eligibility complete within 14 day prior registration PRIOR CONCURRENT THERAPY : No prior treatment head neck cancer Excisional biopsy diagnosis allow</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>